![]() |
| | Home | About CHIPSA | Facilities | Location | Treatments | Research | FAQs | Blog | Contact Us | Admissions |
|
![]() |
At CHIPSA our Directly Observed Therapy (DOT) when integrating with immunonutrition and immunotherapy proceedures produce evidence of significant, sustainable outcomes. |
|
|
|
![]() |
|
![]() |
CHIPSA Gerson Medical is focused on cancer immunotherapy.It is our intent to inform and research the latest findings and facts relating to immunotherapy medicines and immuno-nutritional protocols. Following is a list of medical research areas that CHIPSA and the Gerson Research Organization address and perform medical studies. Our work touches all major facets of immunology and holds enormous clinical promise. Scores of clinical studies are aiming the immuno-stimulating power of dendritic cells at tumors and HIV, and scientists are developing approaches that could target a broad range of infectious agents. Recent studies have shown that dendritic cells also contribute to fever, the process by which the body provides potential immune reaction to eradicate disease cells. This awareness is inspiring dendritic-cell-based medical therapies that treat autoimmune and degenerative disorders. Learn More > Immunonutrition: Beneficial Effects in Surgical Patients
|
| - | - | - | - |
|
|
| |
© 2011 CHIPSA is a trademark of CHIPSA / Gerson Hospital / Medical Center. All rights reserved. |